Sore eyes are the most significant vision-based indicator of COVID-19, according to new research published in the journal BMJ Open Ophthalmology, which calls for a change in the way symptoms are classified. Read more
Screening vital to eliminating COVID transmission risk through donor cornea
Researchers have analysed the prevalence of COVID-19 in human post-mortem ocular tissues, highlighting the importance of the donor screening process. Read more
Ophthalmologists treat rare corneal bee sting
Ophthalmologists have detailed how they treated an unlikely case of a corneal bee sting in a renowned peer-reviewed medical journal this month. Read more
Myopia Profile and CORE join forces
The world’s largest childhood myopia education resource developed by Australian optometry couple Dr Kate and Dr Paul Gifford has formed a new alliance with the renowned Centre for Ocular Research & Education (CORE). Read more
Study shows gene therapy potential to regenerate optic nerve, Aussie professor says
A Melbourne professor has helped lead new research using a gene therapy to regenerate damaged optic nerve fibres, in a discovery that could determine future glaucoma treatments. Read more
Atropine dose comparison shows a clear winner for myopia control
A concentration of 0.05% atropine slowed the rate of myopia progression in pre-teen children compared with two other concentrations of the drug, according to findings published in Ophthalmology. Read more
Cornea resistant to the novel coronavirus – study
A new study has suggested the cornea can resist infection from the novel coronavirus, in findings that bode well for corneal transplants and similar procedures. Read more
Changing visual behaviour of 2020 revealed in new survey
Half of the Australian population is experiencing negative impacts to their eyesight due to rapidly changing lifestyles in 2020, according to new research from Zeiss. Read more
Aussie-developed glaucoma implant performs well in initial trial
A Victorian biopharmaceutical company has reported positive results from a Phase 1 study examining the safety of its biodegradable implant for glaucoma. Read more
New group focuses on how to clear the COVID-19 backlog
The Centre for Eye Research Australia (CERA) has established a new research unit to improve current eyecare models and tackle the backlog of undiagnosed and untreated conditions brought on by the COVID-19 pandemic. Read more